Stoxline.com

Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations

Banco Santander S.A. (SAN)

4.05   0.16 (4.11%) 12-12 16:02
Open: 3.99 Pre. Close: 3.89
High: 4.07 Low: 3.97
Volume: 11,587,929 Market Cap: 68349M
Banco Santander SA is a global bank engaged in retail banking. The firm also offers other services such as wholesale banking, insurance and asset management. Its business operations are spread across Latin America, Continental Europe, and the U.S.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 3.923 - 3.941 3.941 - 3.959
Low: 3.841 - 3.863 3.863 - 3.884
Close: 3.855 - 3.888 3.888 - 3.92

Technical analysis

as of: 2019-12-12 4:03:56 PM
Overall:       
Stoxline posted a BUY today, upgraded from lower rating. Upward movement to be expected.
Target: Six months: 4.93     One year: 5.76
Support: Support1: 3.94    Support2: 3.77
Resistance: Resistance1: 4.22    Resistance2: 4.93
Pivot: 3.91
Moving Average: MA(5): 3.93     MA(20): 3.90
MA(100): 4.01     MA(250): 4.42
MACD: MACD(12,26): -0.03     Signal(9): -0.05
Stochastic oscillator: %K(14,3): 67.07     %D(3): 62.76
RSI: RSI(14): 57.83
52-week: High: 5.25  Low: 3.65  Change(%): -10.6
Average Vol(K): 3-Month: 860109  10-Days: 772106

Price, moving averages and Bollinger Bands

Price and moving averages has closed above its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.
SAN has closed above the upper band by 11.2%. If price is in a uptrend band; this upward trend in price might continue. However a short term pullback inside the band is likely.Bollinger Bands are 47.9% narrower than normal. The narrow width of the bands suggests low volatility as compared to SAN's normal range. The bands have been in this narrow range for 7 bars. This is a sign that the market may be about to initiate a new trend.

Headline News

2019-12-12
Global Osteoarthritis Therapeutics Market 2019-2023 | Evolving Opportunities With Bayer AG and Sanofi | Technavio
LONDON--(BUSINESS WIRE)-- #Biotechnology--Global osteoarthritis therapeutics market is poised to grow by USD 2.56 billion during 2019-2023 at a CAGR of about 8% during the forecast period.

2019-12-12
The Daily Biotech Pulse: European Nod For Amgen, miRagen Overhauls Clinical Pipeline, Tonix Snags Patent Win
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks hitting 52-week highs on Dec. 11) Acceleron Pharma Inc (NASDAQ: XLRN ) Aimmune Therapeutics Inc (NASDAQ: AIMT ) Aprea Therapeutics Inc (NASDAQ: APRE ) Aptose Biosciences Inc (NASDAQ: APTO ) argenx SE – ADR (NASDAQ: ARGX ) ArQule, Inc. (NASDAQ: ARQL ) Arvinas Inc (NASDAQ: ARVN ) Audentes Therapeutics Inc (NASDAQ: BOLD ) Axsome Therapeutics Inc (NASDAQ: AXSM ) Avadel Pharmaceuticals PLC (NASDAQ: AVDL ) Bausch Health Companies Inc (NYSE: BHC ) BioNTech SE – ADR (NASDAQ: BNTX ) Bio-Rad Laboratories, Inc. (NYSE: BIO ) Bristol-Myers Squibb Co (NYSE: BMY ) Cue Biopharma Inc (NASDAQ: CUE ) Deciphera Pharmaceuticals Inc (NASDAQ: DCPH ) Eidos Therapeutics Inc (NASDAQ: EIDX ) Flexion Therapeutics Inc (NASDAQ: FLXN ) Forty Seven Inc (NASDAQ: FTSV ) GlaxoSmithKline plc (NYSE: GSK ) Gossamer Bio Inc (NASDAQ: GOSS ) Immunomedics, Inc. (NASDAQ: IMMU ) Incyte Corporation (NASDAQ: INCY ) IVERIC bio Inc (NASDAQ: ISEE ) Kadmon Holdings Inc (NYSE: KDMN ) Ra Pharmaceuticals Inc (NASDAQ: RARX ) Repro-Med Systems, Inc.

Financial Analysis

Growth
Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Click here to get more fundamental analysis.
Tweet this page Share on Facebook
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  New York Stock Exchange
Sector:  Financial Services
Industry:  Banks - Global
Shares Out. (M) 16620.00
Shares Float (M) 16440.00
% Held by Insiders
% Held by Institutions 1.86
Shares Short (K) 15490
Shares Short P. Month (K)

Stock Financials

EPS 0.482
Book Value (p.s.) 6.860
PEG Ratio
Profit Margin 14.45
Operating Margin
Return on Assets (ttm) 0.5
Return on Equity (ttm) 6.9
Qtrly Rev. Growth 5.1
Gross Profit (p.s.) 2.366
Sales Per Share
EBITDA (p.s.)
Qtrly Earnings Growth -74.80
Operating Cash Flow (M)
Levered Free Cash Flow (M)

Stock Valuations

P/E 8.42
P/E Growth Ratio 0.04
P/BV 0.59
P/S
P/CF

Dividends & Splits

Dividend 0.220
Dividend Yield 0.05
Dividend Pay Date 2019-11-08
Ex-Dividend Date 2019-10-30
Forward Dividend 0.300
Last Split Date 2012-01-11
Last Split Ratio -1e+010
7 Binary Options
Your Ad Here
android_stock_chart
Stock Chart
stoxline_lite
Stoxline Lite
stoxline_pro
Stoxline Pro
Option_Calculator
Option Calculator
(c) 2006-2019 Stoxline.com | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.